GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles

• Status: Completed
• Trial end date: 2007-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

A single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles was reported to increase pregnancy and birth rates. This study was done to evaluate the reproducibility of previous findings.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: V.K.V. American Hospital, Istanbul
• Treatments: Deslorelin; Triptorelin Pamoate

Criteria

Inclusion Criteria:

• Women undergoing embryo transfer following controlled ovarian hyperstimulation with a long GnRH agonist protocol, oocyte pick-up and ICSI.

• Embryo transfer performed on day 3.

Exclusion Criteria:

• Participation in another trial that was being conducted in our unit at the same time.

• Preimplantation genetic screening cycles.

• Day 5 embryo transfers.